Gelteq (GELS) Total Current Liabilities (2023 - 2025)
Gelteq's (GELS) quarterly Total Current Liabilities came in at $3.9 million in Q4 2025, down 6.11% year-on-year from $4.1 million in Q4 2024, and up 6.88% quarter-over-quarter from $3.6 million in Q2 2025.
Gelteq (GELS) Total Current Liabilities (2023 - 2025) Analysis & Trends
Gelteq's Total Current Liabilities history runs 3 years deep, the most recent figure standing at $3.9 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 6.11% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $3.9 million, a 6.11% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, up 41.57% from the prior year.
- Total Current Liabilities improved to $3.9 million in Q4 2025 per GELS's latest filing, from $3.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $4.1 million in Q4 2024 and bottomed at $911994.5 in Q2 2023.
- The 3-year median for Total Current Liabilities is $3.6 million (2025), against an average of $3.0 million.
- Across the five-year window, Total Current Liabilities soared 179.37% in 2024 and decreased 6.11% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $911994.5 in 2023, then jumped by 350.22% to $4.1 million in 2024, then dropped by 6.11% to $3.9 million in 2025.
- Per Business Quant, the three latest GELS Total Current Liabilities figures stand at $3.9 million (Q4 2025), $3.6 million (Q2 2025), and $4.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Dec 31, 2024 | 4.11 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Jun 30, 2023 | 911,994.54 |